EGFR Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 5318 | AEE 788 |
| Potent EGFR and VEGFR inhibitor | |
| 6812 | Afatinib dimaleate |
| Potent dual specificity EGFR/HER2 inhibitor; active in vivo | |
| 1276 | AG 1478 hydrochloride |
| Highly potent EGFR-kinase inhibitor | |
| 0414 | AG 490 |
| EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor | |
| 5916 | Canertinib dihydrochloride |
| Potent EGFR kinase inhibitor | |
| 6231 | Dacomitinib |
| Potent irreversible pan ErbB inhibitor | |
| 7194 | Erlotinib Hydrochloride |
| Potent, reversible EGFR tyrosine kinase inhibitor | |
| 1110 | Genistein |
| EGFR kinase inhibitor. Also estrogen and PPARγ ligand | |
| 2239 | GW 583340 dihydrochloride |
| Potent dual EGFR/ErbB2 inhibitor; orally active | |
| 6813 | Ibrutinib |
| Potent ErbB4 inhibitor; also inhibits BTK | |
| 3000 | Iressa |
| Orally active, selective EGFR inhibitor | |
| 6962 | JBJ-03-142-02 |
| Highly potent EGFR and ErbB2 inhibitor; inhibts wild type and mutated receptors | |
| 3352 | JNJ 28871063 hydrochloride |
| Potent ErbB receptor family inhibitor | |
| 6811 | Lapatinib |
| Potent and selective dual ErbB2 (HER-2) and EGFR inhibitor | |
| 7371 | Neratinib |
| Potent HER2 receptor tyrosine kinase and EGFR kinase inhibitor | |
| 2615 | PD 158780 |
| Potent ErbB receptor family inhibitor | |
| 2794 | PP 3 |
| EGFR-kinase inhibitor. Also Src kinase negative control | |
| 3599 | TAK 165 |
| Potent and selective ErbB2 inhibitor | |
| 7640 | Tucatinib |
| Potent and selective ErbB2 inhibitor | |
| 6290 | WZ 4002 |
| Potent mutant-selective EGFR inhibitor |
Angiogenesis in Cancer Life Science Poster
Our Angiogenesis in Cancer poster summarizes the pathogenesis of angiogenesis in cancer, as well as some of the main angiogenesis therapeutic targets.
Request copyDownload PDF